par Feremans, Walter
;Bastin, Geneviève
;Le Moine, F;Ravoet, Christophe;Delville, Jean Pierre;Pradier, Olivier
;Wallef, G;Dupont, Etienne
;Capel, Paul
;Lambermont, Micheline 
Référence European journal of haematology, 56, 5, page (278-282)
Publication Publié, 1996-05






Référence European journal of haematology, 56, 5, page (278-282)
Publication Publié, 1996-05
Article révisé par les pairs
Résumé : | Very high-dose chemotherapy with autologous blood stem cell (BSC) rescue becomes more and more widely performed. In order to simplify the technique, a large volume apheresis programme combined with an uncontrolled rate cryopreservation at –80°C was developed. Twenty-six patients suffering from multiple myeloma (n = 8), non-Hodgkin's lymphoma (n = 7), dysgerminoma (n = 4), breast cancer (n = 3), Hodgkin's disease (n = 2), acute lymphoblastic leukaemia (n = 1) and acute myelocytic leukaemia (n = 1) were autografted after a classical high-dose chemotherapy regimen. A single large volume apheresis was sufficient to obtain the threshold value of CD34+ BSC in 24/26 transplantations. The haematological recovery was favourably comparable with the previously published data obtained with controlled rate frozen BSC: median time to granulocytes > 1000/μL and to a self-supporting platelet count > 20,000/μL, respectively, 10.5 and 12 d. The treatment-related mortality was confined to 1/26 BSCT. These results indicate that this easy and cost-saving policy of BSCT is efficacious and safe: sustained long-term haematopoiesis, reduced morbidity and mortality were observed. |